Author:
Michael Claudia,Bierbach Uta,Frenzel Katrin,Lange Thoralf,Basara Nadezda,Niederwieser Dietger,Mauz-Körholz Christine,Preiss Rainer
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference34 articles.
1. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.;Cuenca-Estrella;J Antimicrob Chemother,1998
2. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.;Espinel-Ingroff;J Clin Microbiol,1998
3. Voriconazole: a second-generation triazole.;Chandrasekar;Drugs Today (Barc),2001
4. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.;Espinel-Ingroff;Mycopathologia,2001
5. Correlation of Neo-Sensitabs tablet diffusion assay on three media, with CLSI broth microdilution M27-A2 and disk diffusion M44-A methods for susceptibility testing of Candida spp. and Cryptococcus neoformans, with amphotericin b, caspofungin, fluconazole, itraconazole, and voriconazole.;Espinel-Ingroff;J Clin Microbiol,2007
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献